Category : Seeking Alpha

Dyadic to Report Third Quarter 2025 Financial Results on Wednesday, November 12, 2025

Eviden awarded by NATO the modernization of communications for the Spanish Air and Space Force

Press Release

Eviden sélectionné par l'OTAN pour la modernisation des communications de l'armée de l'air et de l'espace espagnole

Communiqué de presse

Virtu Announces Third Quarter 2025 Results

NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Virtu Financial, Inc. (NYSE: VIRT), a leading provider of financial services and products that leverages cutting edge technology to deliver innovative, transparent trading solutions to its clients and liq...

Verisk Reports Third-Quarter 2025 Financial Results

JERSEY CITY, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Verisk (Nasdaq: VRSK), a leading global data analytics and technology provider, today announced results for the third quarter ended September 30, 2025. The earnings release is available on the co...

Panoro Minerals Ltd. Announces Brokered LIFE Offering for Gross Proceeds of up to C$5 Million

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

Delårsrapport 3. kvartal 2025

Vedlagt følger delårsrapport for 3. kvartal 2025 for DLR Kredit A/S.

Chicago Atlantic BDC, Inc. Announces Third Quarter 2025 Financial Results Conference Call

NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Chicago Atlantic BDC, Inc. (the “Company”) (NASDAQ: LIEN), a specialty finance company that has elected to be regulated as a business development company, today announced details for the release of its fi...

Kirby Corporation Announces 2025 Third Quarter Results

HOUSTON, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Kirby Corporation (“Kirby”) (NYSE: KEX) today announced net earnings attributable to Kirby for the third quarter ended September 30, 2025, of $92.5 million or $1.65 per share, compared with earnings of $90...

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2025

― Announced encouraging results in July 2025 from the 12 mg dose cohort of the Phase 1b PIONEER trial of pociredir in sickle cell disease (SCD) ―

Apuiat Wind Farm Reaches Commercial Operation – Marking a New Energy Era in Quebec

UASHAT, Canada, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Apuiat Wind Farm L.P., a 50-50 partnership between the Innu communities and Boralex Inc., is proud to announce that the Apuiat Wind Farm has reached commercial operation. The 200 MW facility is loca...

Mise en service commerciale du parc éolien Apuiat : début d’une nouvelle ère énergétique pour le Québec

UASHAT, Canada, 29 oct. 2025 (GLOBE NEWSWIRE) -- Parc éolien Apuiat S.E.C., un partenariat 50-50 regroupant les communautés innues partenaires du projet (les « Innus ») et Boralex inc. (« Boralex »), est fier d’annoncer aujourd’hui la mise en servi...

Axogen, Inc. Reports Third Quarter 2025 Financial Results

Raises Full Year Revenue Guidance to at Least 19% Growth or $222.8 million Raises Full Year Revenue Guidance to at Least 19% Growth or $222.8 million

Lifecore Biomedical Selected as New Commercial Manufacturing Partner by Leading Global Pharmaceutical Company

Lifecore to Execute Commercial Site Transfer and Become New Supplier of Choice for Leading Commercial Injectable Pharmaceutical Product

Avalo Therapeutics Announces Completion of Enrollment in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa

WAYNE, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases, today announced that the C...